This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2022 Apr:105:108575.

doi: 10.1016/j.intimp.2022.108575. Epub 2022 Feb 1.

Corrigendum to "Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis" [Int. Immunopharmacol. 99 (2021) 108005]

Nagwa I Mohamed¹, Ghada M Suddek¹, Dalia H El-Kashef²

Affiliations

Affiliations

¹ Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
² Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt. Electronic address: dalia_elkashef@mans.edu.eg.

PMID: 35115257
DOI: 10.1016/j.intimp.2022.108575

Published Erratum

Corrigendum to "Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis" [Int. Immunopharmacol. 99 (2021) 108005]

Nagwa I Mohamed et al. Int Immunopharmacol. 2022 Apr.

. 2022 Apr:105:108575.

doi: 10.1016/j.intimp.2022.108575. Epub 2022 Feb 1.

Authors

Nagwa I Mohamed¹, Ghada M Suddek¹, Dalia H El-Kashef²

Affiliations

¹ Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
² Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt. Electronic address: dalia_elkashef@mans.edu.eg.

PMID: 35115257
DOI: 10.1016/j.intimp.2022.108575

Retraction in

Retraction notice to "Corrigendum to "Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis" [Int. Immunopharmacol. 105 (2022) 108575].
Mohamed NI, Suddek GM, El-Kashef DH. Mohamed NI, et al. Int Immunopharmacol. 2025 Feb 20;148:114169. doi: 10.1016/j.intimp.2025.114169. Epub 2025 Feb 4. Int Immunopharmacol. 2025. PMID: 39904683 No abstract available.

No abstract available

PubMed Disclaimer

Erratum for

Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis.
Mohamed NI, Suddek GM, El-Kashef DH. Mohamed NI, et al. Int Immunopharmacol. 2021 Oct;99:108005. doi: 10.1016/j.intimp.2021.108005. Epub 2021 Jul 27. Int Immunopharmacol. 2021. Retraction in: Int Immunopharmacol. 2025 Feb 20;148:114171. doi: 10.1016/j.intimp.2025.114171. PMID: 34330056 Retracted.

Similar articles

Retraction notice to "Corrigendum to "Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis" [Int. Immunopharmacol. 105 (2022) 108575].
Mohamed NI, Suddek GM, El-Kashef DH. Mohamed NI, et al. Int Immunopharmacol. 2025 Feb 20;148:114169. doi: 10.1016/j.intimp.2025.114169. Epub 2025 Feb 4. Int Immunopharmacol. 2025. PMID: 39904683 No abstract available.
Retraction notice to "Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis" [Int. Immunopharmacol. 99 (2021) 108005].
Mohamed NI, Suddek GM, El-Kashef DH. Mohamed NI, et al. Int Immunopharmacol. 2025 Feb 20;148:114171. doi: 10.1016/j.intimp.2025.114171. Epub 2025 Feb 1. Int Immunopharmacol. 2025. PMID: 39894706 No abstract available.
Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis.
Mohamed NI, Suddek GM, El-Kashef DH. Mohamed NI, et al. Int Immunopharmacol. 2021 Oct;99:108005. doi: 10.1016/j.intimp.2021.108005. Epub 2021 Jul 27. Int Immunopharmacol. 2021. Retraction in: Int Immunopharmacol. 2025 Feb 20;148:114171. doi: 10.1016/j.intimp.2025.114171. PMID: 34330056 Retracted.
Corrigendum to "Icosapent ethyl alleviates acetic acid-induced ulcerative colitis via modulation of SIRT1 signaling pathway in rats" [Int. Immunopharmacol. 115 (2023) 109621].
Ahmed Abdelsameea A, Ebrahim Alsemeh A, Alabassery N, Samy W, Fawzy A, Abbas NAT. Ahmed Abdelsameea A, et al. Int Immunopharmacol. 2024 Oct 25;140:112647. doi: 10.1016/j.intimp.2024.112647. Epub 2024 Aug 5. Int Immunopharmacol. 2024. PMID: 39107183 No abstract available.
Corrigendum to "Laquinimod attenuates oxidative stress-induced mitochondrial injury and alleviates intervertebral disc degeneration by inhibiting the NF-κB signaling pathway" [Int. Immunopharmacol. 131 (2024) 111804].
Xiao H, Wang K, Peng L, Yin Z. Xiao H, et al. Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113585. doi: 10.1016/j.intimp.2024.113585. Epub 2024 Nov 14. Int Immunopharmacol. 2024. PMID: 39542746 No abstract available.

See all similar articles

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.